European Bio Immune(G)ene Medicine Association, France
Keynote: J Clin Cell Immunol
At a time when emerging concepts capable of revolutionizing old medical paradigms are flourishing, such as systems biology, integrative medicine or personalized medicine, it is of the utmost interest to observe how such concepts can be applied in the context of a therapeutic method that is both innovative and devoid of any undesirable effect, because it simply seeks to play a regulatory role. The aim of this method called Bio Immun(G)ene Medicine (BI(G)MED) is to make the best use of all the molecular resources available to the cell to restore the homeostasis of the latter at its various levels of genome, epigenome, transcriptome, proteome and metabolome. To achieve this goal, it is of course essential to use means borrowed to nano-biotechnologies to ensure a high efficiency of the molecules made available to the cells to facilitate their self-regulation and thanks to a therapeutic model essentially based on true biomimicry. The description of one or the other clinical case will show how this method can be effective in poly-pathologies, sometimes very advanced and often recurrent, without ever harming the patient.
Gilbert Glady has completed his MD at the age of 27 years from Strasbourg University of Medicine and postdoctoral studies from Besançon and Paris-Nord Universities of Medicine. He got expertise in immunology and immunogenetics and also developed interest for alternative medicines. So he became the creator of the BI(G)MED method and director of EBMA, the European association for training the medical profession at the BI(G)MED. He has participated in numerous international congresses in the field of immuno-allergology, infectiology and oncology with posters and oral presentations.